The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1173
ISSUE1173
January 5, 2004
Addendum: Alfuzosin (Uroxatral) -- Another Alpha1-blocker for Benign Prostatic Hyperplasia
Med Lett Drugs Ther. 2004 Jan 5;46(1173):4
Disclosures
Objective(s)
SUMMARY: Addendum: The table in the article on alfuzosin for treatment of benign prostatic hyperplasia (January 5, 2004, vol. 46, p.1) omitted the generic alpha1-blockers. The complete table with prices updated to December 2003 is now in the issue.
© The Medical Letter, Inc. All Rights Reserved.
The Medical Letter, Inc. does not warrant that all the material in this publication is accurate and
complete in every respect. The Medical Letter, Inc. and its editors shall not be held responsible for any
damage resulting from any error, inaccuracy, or omission.
This article has been freely provided.
Previous article